Clinical
RSSArticles
-
Aspirin Matches Xarelto Efficacy Regarding VTE Prophylaxis After Knee or Hip Surgery
The authors of a recent study concluded that among hip or knee arthroplasty patients who receive five days of postoperative rivaroxaban, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism.
-
Promising News About Zika Vaccine
Clinicians look forward to confirmation of vaccine efficacy in a large population.
-
Influenza Increases Rate of Myocardial Infarction
The proportion of patients who succumb to influenza pneumonia vs. those who incur bacterial pneumonia subsequent to pneumonia vs. all other incident pneumonias that occur concomitantly with flu season is not readily discernible.
-
Obstructive Sleep Apnea: Oral Appliances
The diversity of treatment options currently available should stimulate optimism that the consequences of obstructive sleep apnea can be improved successfully in most patients.
-
Inhaled Corticosteroids and Fracture Risk
Clinicians should strive to use the minimum inhaled corticosteroids necessary to achieve symptomatic improvements in COPD patients.
-
Rivaroxaban vs. Aspirin for Prevention of VTE
Might direct oral coagulants offer some advantage for extended venous thromboembolism (VTE) thromboprophylaxis in patients undergoing knee or hip arthroplasty who are known to suffer an increased risk of VTE in the immediate postoperative period?
-
Comparing GLP-1 Agonists
There are more similarities than differences among the seven currently available glucagon-like peptide-1 (GLP-1) receptor agonists. The most recently FDA-approved GLP-1 receptor agonist, once-weekly semaglutide (Ozempic), was compared in a head-to-head trial to once-weekly exenatide-ER (Bydureon).
-
What Can Be Said With LBBB?
The ECG in the figure was obtained from a patient with new-onset chest pain. It was interpreted as showing complete left bundle branch block (LBBB). Thus, the provider reasoned that “it is impossible to tell if anything acute is going on because there is LBBB.” Do you agree with that assessment?
-
Clinical Briefs
In this section: Managing postprandial glucose excursions in diabetic patients, strategies for improving long-term outcomes for obesity patients, and effectively treating Crohn's disease.
-
Vancomycin HCl for Oral Solution (Firvanq)
Vancomycin oral solution is indicated for adults and pediatric patients < 18 years of age for Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).